Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rain Oncology Inc (NQ: RAIN )

10.42 +0.17 (+1.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,702
Open 10.19
Bid (Size) 10.04 (1)
Ask (Size) 12.14 (1)
Prev. Close 10.25
Today's Range 10.10 - 10.94
52wk Range 2.150 - 14.48
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
What 4 Analyst Ratings Have To Say About Rain Oncology
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
 
Via Benzinga

Performance

YTD
+30.25%
+30.25%
1 Month
-10.25%
-10.25%
3 Month
+80.90%
+80.90%
6 Month
+33.25%
+33.25%
1 Year
+35.85%
+35.85%

More News

Read More
The Week In Charts - Becoming A Successful Trader
Via Talk Markets
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
$10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Rain Therapeutics Experimental Cancer Therapy Shows Encouraging Tumor Regression Activity
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Earnings Scheduled For November 10, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Via Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Via Benzinga
Rain Therapeutics Concludes Enrolment In Late-Stage Tissue Cancer Study, Expects Topline Data In H1 2023
Via Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
Via Benzinga
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.